Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Atwood Insider Profile
11 Followers
Brian Atwood, Director at Immune Design, holds 19.73M shares in CERo Therapeutics Holdings (Ticker: CERO), holds 49.65K shares in Atreca (Ticker: BCEL), holds 160.19K shares in Clovis Oncology (Ticker: CLVSQ).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-6.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Atwood holds in companies
Most Profitable Insider Trade
Stock:
Immune Design
(IMDZ)
(IMDZ)
Rating:Informative Buy
Date:Jul 31, 2014 - Jul 31, 2015
Return:+61.30%
The most profitable trade made by Brian Atwood
Brian Atwood's Trading History
Immune Design
Jul 31, 2014
―
Uninformative Buy
2.50M
$25.84M
Atreca
Jun 24, 2019
―
Uninformative Buy
―
$4.47K
CERo Therapeutics Holdings
Oct 02, 2024
Director
Uninformative Buy
1.94M
$1.11M
Five Prime Therapeutics
Sep 23, 2013
―
Uninformative Buy
―
$41.50M
OpGen
May 12, 2015
Director, Ten Percent Owner
Uninformative Buy
―
$1.85M
Clovis Oncology
Jun 28, 2017
―
Uninformative Buy
―
$2.40K
Veracyte
Nov 04, 2013
Director, Ten Percent Owner
Uninformative Buy
―
$868.18K
Cadence Pharma
Mar 21, 2014
―
Uninformative Sell
70.10M
―
Trius Therap
―
―
―
―
List of latest transactions for each holding click on a transaction to see Brian Atwood's performance on stock
You May Also Like
Brian Atwood insider profile FAQ
What is the percentage of profitable transactions made by Brian Atwood?
The percentage of profitable transactions made by Brian Atwood is 50%.
What is the average return per transaction made by Brian Atwood?
The average return per transaction made by Brian Atwood is -6.30%.
What stocks does Brian Atwood hold?
Brian Atwood holds: IMDZ, BCEL, CERO, FPRX, OPGN, CLVSQ, VCYT, CADX, TSRX stocks.
What was Brian Atwood’s latest transaction?
Brian Atwood latest transaction was an Uninformative Buy of $1.94M.
What was Brian Atwood's most profitable transaction?
Brian Atwood’s most profitable transaction was an Informative Buy of IMDZ stock on July 31, 2014. The return on the trade was 61.30%.
What is Brian Atwood's role in Immune Design?
Brian Atwood's role in Immune Design is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.